Do you know what to do when counseling a patient on a drug with a REMS designation? Learn more with new guidance from the FDA. FDA Expert Commentaries and Interviews http://ift.tt/2EPmsJo
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου